Abstract. Lung cancer is the most common cause of cancer mortality and new cases are on the increase worldwide. However, the treatment of lung cancer remains unsatisfactory. Curcumin has been shown to induce cell death in many human cancer cells, including human lung cancer cells. However, the effects of curcumin on genetic mechanisms associated with these actions remain unclear. Curcumin (2 µM) was added to NCI-H460 human lung cancer cells and the cells were incubated for 24 h. Total RNA was extracted from isolated cells for cDNA synthesis, labeling, microarray hybridization and flour-labeled cDNA hybridized on chip. Localized concentrations of fluorescent molecules were detected and quantified using Expression Console software (Affymetrix) with default RMA parameters. GeneGo software was used for the key genes involved and their possible interaction pathways. The results showed that ~170 genes were significantly upregulated and 577 genes were significantly downregulated in curcumin-treated cells. Specifically, the up-and downregulated genes included CCNE2, associated with DNA damage; ID3, associated with cell survival and 146 genes with a >2-to 3-fold change including the TP53INP1 gene, associated with DNA damage; CDC6, CDCA5, TAKMIP2, CDK14, CDK5, CDCA76, CDC25A, CDC5L and SKP2, associated with cell cycle; the CARD6, ID1 and ID2 genes, associated with cell survival and the BRMS1L, associated with cell migration and invasion. Additionally, 59 downregulated genes exhibited a >4-fold change, including the DDIT3 gene, associated with DNA damage; while 97 genes had a >3-to 4-fold change including the DDIT4 gene, associated with DNA damage; the CCPG1 gene, associated with cell cycle and 321 genes with a >2-to 3-fold including the GADD45A and CGREF1 genes, associated with DNA damage; the CCPG1 gene, associated with cell cycle, the TNFRSF10B, GAS5, TSSC1 and TNFRSF11B gene, associated with cell survival and the ARHAP29 and CADM2 genes, associated with cell migration and invasion. In conclusion, gene alterations provide information regarding the cytotoxic mechanism of curcumin at the genetic level and provide additional biomarkers or targets for the treatment of human lung cancer.
Introduction
Lung cancer, a leading cause of cancer-associated mortality wordwide, is one of the most aggressive human cancers and almost 80% of lung cancer-related deaths are non-small-cell lung cancer (NSCLC) (1, 2) . Despite recent improvements in chemotherapy and molecular-targeted therapy in lung cancer patients, the outcome of lung cancer remains poor. Treatments can also cause serious side effects that affect quality of life of patients (3) . Although there has been considerable progress in the diagnosis and treatment of lung cancer, the overall 5-year survival rate of NSCLC patients remains <15% (4) . Thus, studies have focused on new anticancer drugs derived from natural products and attempted to improve the disadvantage of the treatment of lung cancer.
Curcumin, a component of turmeric, is derived from the rhizome of Curcuma longa. Previous findings have shown that curcumin has anticancer activities for various types of cancer in vitro and in vivo (5) . Curcumin has been found to
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interfere with pathways that are overexpressed in cancer cells, such as NfκB, STAT3 and PI3K/Akt to induce cell death in tumors (6) . Curcumin also acts as a chemoprotective agent (7) (8) (9) . Intraperitoneally administered curcumin in rats was able to decrease brain-implanted glioblastomas in vivo (10) . Additionally, curcumin induces autophagy by activating the AMPK signaling pathway in human lung adenocarcinoma cells (11) . Curcumin inhibits migration and invasion of human lung cancer cells through inhibition of the Rac1/PAK1 signaling pathway and MMP-2 and MMP-9 (12) . Recently, it was reported that curcumin significantly reduced the tumor growth of orthotopic human NSCLC xenografts and increased survival of treated athymic mice (13) . Cells maintain normal functions and survival via genome integrity. However, genome instability of cells causes genetic aberrations and is considered a hallmark of most types of cancer (14) . After the presence of DNA damage, p53 protein can be activated to promote important gene expressions that are involved in cell cycle arrest, DNA repair and apoptosis (15) . Thus, identification of genetic abnormalities in NSCLC has been used for the development of targeted therapeutic approaches in NSCLC treatment. Targeting tumors carrying mutations in EGfR or a fusion of the EML4 and ALK genes used clinically have been successful as first-line therapies in NSCLC (16) (17) (18) . Therefore, it is imperative to identify gene expression or inhibition in NSCLC affected by test compounds or drugs to investigate the molecular mechanism to determine the function of these agents. Although curcumin has been demonstrated to induce cytotoxic effects on many human cancer cells, how associated total genes in human lung cancer cells (NSCLC) are affected by curcumin remains to be determined. Thus, we used cDNA microarray to investigate the altered gene expression in NCI-H460 cells following exposure to curcumin and the results indicated that curcumin altered certain gene expression associated with apoptosis.
Materials and methods

Chemicals and reagents.
Curcumin and dimethylsulfoxide (DMSO) were obtained from Sigma Chemical Co. (St. Louis, MO, USA). Culture medium RPMI-1640, fetal bovine serum (FBS), 1% L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin were obtained from Gibco-BRL (Grand Island, NY, USA). Curcumin was dissolved in DMSO and stored at -20˚C prior to use.
Lung cancer cells.
The NCI-H460 human NSCLC cell line was purchased from the Food Industry Research and Development Institute (Hsinchu, Taiwan). The cells were cultured in RPMI-1640 medium and supplemented with 10% FBS, 1% L-glutamine and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA) at 37˚C in a humidified atmosphere of 95% air and 5% CO 2 air. The cells were split every 4 days to maintain exponential growth and were harvested with 0.025% trypsin and 0.52 mM EDTA in phosphate-buffered saline (PBS), plated at required cell numbers and allowed to adhere for ~24 h prior to treatment.
cDNA microarray assay used for gene expression in NCI-H460 cells following exposure to curcumin. NCI-H460 cells (5x10 5 cells/ml) were kept in 12-well plates with RPMI-1640 medium for 24 h and then incubated with or without 2 µM of curcumin for 24 h. After treatment, the cells were collected and total RNA from each sample was extracted using a Qiagen RNeasy Mini kit (Qiagen Inc., Valencia, CA, USA) as previously described (19) . Total RNA from curcumin-treated and -untreated cells was quantified and used for cDNA synthesis, labeling and microarray hybridization, followed by flour-labeled cDNA hybridizing their complements on the chip (Affymetrix GeneChip Human Gene 1.0 ST array; Affymetrix, Santa Clara, CA, USA) as previously described (19) . On the chip, the resulting localized concentrations of fluorescent molecules were detected and quantified (Asia BioInnovations Corporation, Taipei, Taiwan) and data were further analyzed using Expression Console software (Affymetrix) with default RMA parameters (19, 20) . Up-or downregulated gene expressions was affected by DMC in NCI-H460 cells and a ≥2-fold change was recorded and identified. Data were representative of three independent assays.
Statistical analysis.
The results were representative of three assays. Differences between curcumin-treated and -untreated groups were presented up to 2-fold changes, with + signifying upregulation and -, downregulation.
Results
Curcumin induces the up-and downregulated gene expression in NCI-H460 cells.
The NCI-H460 cells were incubated with or without 2 µM of curcumin and collected to extract total RNA. The cells were then used for cDNA microarray analysis and results are shown in Tables I and II. Table I indicated that 4 genes exhibited >4-fold change, 20 genes were >3-to 4-fold including the CCNE2 gene, associated with DNA damage; the ID3 gene, associated with cell survival and 146 genes exhibited a >2-to 3-fold change, including the TP53INP1 gene, associated with DNA damage; the CDC6, CDCA5, TAKMIP2, CDK14, CDK5, CDCA76, CDC25A, CDC5L and SKP2 gene, associated with the cell cycle; the CARD6, ID1 and ID2 genes, associated with cell survival and the BRMS1L gene, associated with cell migration and invasion. Table II shows that 59 genes were downregulated with >4-fold change including the DDIT3 gene, associated with DNA damage, while 97 genes had a >3-to 4-fold change, including the DDIT4 gene, associated with DNA damage; the CCPG1 gene, associated with the cell cycle and 321 genes exhibited a >2-to 3-fold change including the GADD45A and CGREF1 genes, associated with DNA damage; the CCPG1 gene, associated with the cell cycle; the TNFRSF10B, GAS5, TSSC1 and TNFRSF11B genes, associated with cell survival; and the ARHAP29 and CADM2 genes, associated with cell migration and invasion.
Curcumin affects the gene expression scores as measured by GeneGo analysis program in NCI-H460 cells by the number of pathway networks.
Curcumin-treated or -untreated cells were performed by cDNA microarray and then processed using GeneGo analysis. The results are shown in 
Discussion
It has been demonstrated that curcumin induced biological activities including anticancer function in vitro and in vivo.
However, how curcumin affects gene expression and the associated signaling pathways in human lung cancer cells remains to be determined. Thus, we investigated the up-and downregulation of associated genes with cell cycle, DNA damage, cell survival and cell migration and invasion in NCI H460 cells. In the present study, we found several genes involved DNA damage and repair were increased, such as cyclin E2 (CCNE2), which was increased 3.79-fold. It has also been reported that following cell induction DNA damage led to cell cycle arrest (21) . The tumor protein p53 inducible nuclear protein 1 (TP53INP1) was increased 2.09-fold and after DNA damage the p53 protein expression was also increased (22) . The results showed that the TP53INP1 gene, associated with DNA damage was increased 2.09-fold, the CDC6, TAKMIP2, CDCA5, CDK14, CDK5, CDCA76, CDC25A, CDC5L and SKP2, associated with cell cycle were increased 2.56-, 2.31-, 2.26-, 2.12-, 2.11-, 2.09-, 2.06-, 2.02-and 2.02-fold, respectively, associated with cell cycle, while the CARD6, ID1 and ID2 genes, associated with cell survival were increased 2.99-, 2.70-and 2.12-fold. It was also found that the BRMS1L gene, associated with cell migration and invasion, was increased 2.27-fold. It was reported that tumor protein 53-induced nuclear protein 1 (TP53INP1) is a stress-induced p53-target gene function that represses tumorigenesis (23) . The cell cycle-dependent centrosomal localization of Cdc6 in the S and G2 phases is considered to have a novel function of Cdc6 in centrosomes (24) . CDCA5 and CDK5 have been found to play an important role in the cell cycle (25) . It was reported that the mitotic CDK14/cyclin Y complex promotes Wnt signaling (26) . Moreover, Cdc25 is known to be involved cell cycle regulation (27) . Caspase recruitment domain 6 (CARD6), a microtubule-interacting protein, belongs to the CARD family (28) . CARD6 may be a novel target for the treatment of pathological cardiac hypertrophy and failure (29) . ID (inhibitor of differentiation and DNA binding) comprises the ID1, ID2, ID3 and ID4 proteins, which are involved in cancer progression (30) . ID1 (inhibitor of differentiation and DNA binding 1) was reported to strongly correlate with various types of tumors, including lung cancer (31,32). The results also show that curcumin decreased several gene expressions associated with DNA damage, cell cycle, cell survival and cell migration and invasion. For example, DDIT3, DDIT4, GADD45A and CGREf1 were decreased 5.51-, 3.19-, 2.31-and 2.31-fold, respectively, which was associated with DNA damage. Curcumin decreased 3.02-fold of the CCPG1 gene expression which was associated with cell cycle progression and the TNFRSF10B, TSSC1, GAS5 and TNFRSF11B genes were decreased 2.17-, 2.03-, 2.03-and 2.02-fold, which was associated with cell survival. furthermore, curcumin decreased two gene expressions at 2.15-and 2.06-fold, respectively, which associated with cell migration. It was reported that the induction of DNA-damage-inducible transcript 3 (DDIT3) was observed in the liver of mice exposed to coal mining and this gene is frequently upregulated in response to cell stress and DNA damage (33) . DNA-damage-inducible transcript 4 (DDIT4) is involved in multiple biological settings such as inhibiting mTORC1 signaling and regulating the production of reactive oxygen species (35, 36) , which was also associated with DNA damage. It was demonstrated that myristicin, an allylbenzene, is a major active component of various spices inducing DNA damage signalling (ATM) and stress response (GADD45A and GADD45G) in leukemia cells (34) . The TNFRSF10B gene which encodes the apoptotic death receptor TNFRSF10B was associated with cell death (38). It was also reported that the recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer survival (35) . Growth arrest-specific 5 (GAS5) is a non-coding gene that hosts a number of small nucleolar RNAs (snoRNAs) and it has been suggested to play a tumor suppressive role (36, 37) .
The results of the present study indicated that a number of genes were associated with DNA damage and repair, cell cycle check point, cell survival and cell migration and invasion in NCI-H460 cells following exposure to curcumin. Based on these observations, we determined these associated genes with possible signaling complex interactions. Thus, future investigations are needed to expand or append our current findings and possible understandings. These genes were affected by curcumin, which provides more information for the understanding of the cytotoxic mechanism of curcumin at the genetic level. Furthermore, it provides potentially useful biomarkers or targets in clinic for the diagnosis and treatment of human lung cancer.
